Fangfang Bi
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Biochemistry top 5%
- Geriatrics and Gerontology top 10%
- Nephrology top 10%
- Parathyroid Disorders and Treatments 3
- Chronic Kidney Disease and Diabetes 3
-
- Inflammasome and immune disorders 7
- RNA modifications and cancer 4
- Heme Oxygenase-1 and Carbon Monoxide 4
-
- Cancer-related molecular mechanisms research 3
-
- Autophagy in Disease and Therapy 3
- Co-authors
- Cuicui ChangYuhua ChenJiao MengWei LiuHua LiJinhua ZhongXin‐Fu ZhouShantha L. Kosaraju
- Journals
- SHILAP Revista de lepidopterología (1 paper)Brain Research (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fangfang Bi
28 papers receiving 979 citations
Peers
Comparison fields: 5 of 96
- Neurology 130
- Biochemistry 83
- Geriatrics and Gerontology 52
- Nephrology 80
- Biological Psychiatry 27
Countries citing papers authored by Fangfang Bi
This map shows the geographic impact of Fangfang Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Bi more than expected).
Fields of papers citing papers by Fangfang Bi
This network shows the impact of papers produced by Fangfang Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Bi. The network helps show where Fangfang Bi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fangfang Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 13 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 54 | |
| 11 | 2019 | 79 | |
| 12 | 2019 | 56 | |
| 13 | 2019 | 55 | |
| 14 | 2019 | 69 | |
| 15 | 2018 | 47 | |
| 16 | 2018 | 71 | |
| 17 | 2018 | 155 | |
| 18 | 2016 | 31 | |
| 19 | 2009 | 170 | |
| 20 | [Reversion of the malignant phenotype of gastric cancer by c-erbB-2 specific ribozyme]. | 1999 | 1 |
About Fangfang Bi
Fangfang Bi is a scholar working on Nephrology, Neurology and Molecular Biology, having authored 33 papers that have together received 992 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), RNA modifications and cancer (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Parathyroid Disorders and Treatments (3 papers), Chronic Kidney Disease and Diabetes (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Cancer-related molecular mechanisms research (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Neurology (130 citations), Biochemistry (83 citations) and Geriatrics and Gerontology (52 citations). Fangfang Bi has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Cuicui Chang, Yuhua Chen, Jiao Meng, Wei Liu, Hua Li, Jinhua Zhong, Xin‐Fu Zhou, Shantha L. Kosaraju, Yan‐Jiang Wang and Wangsen Cao. Their work appears in journals such as SHILAP Revista de lepidopterología, Brain Research and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.